SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

SynAct Pharma Q3 After-Tax Loss Narrows 10% to SEK 32.18 Million

SquawkNews Desk 2 updates Updated Nov 03, 2026, 06:40 AM UTC

Story updates

06:40:17 AM UTC
SquawkNews
Sweden's SynAct Pharma Q3 net loss narrows as expenses fall
06:40:21 AM UTC
SquawkNews
Sweden's SynAct Pharma Q3 net loss narrows as expenses fall Overview Sweden biotech firm's Q3 net lo

Related stories

Virgin Media O2 to cut jobs and halt fibre rollout Virgin Media O2 plans job cuts and a halt to its fibre rollout, according to a Reuters headline. M impact | EQUITY | Nov 03, 2026, 07:43 AM UTC Krafton to acquire 300 billion won of its own shares M impact | EQUITY | Nov 03, 2026, 07:43 AM UTC Alticast Raises KRW 1.49 Billion in Private Placement Alticast raised KRW 1.49 billion through a private placement. L impact | EQUITY | Nov 03, 2026, 07:42 AM UTC Gomero Group Swings to Q3 Operating Loss of Kr 398,000 M impact | EQUITY | Nov 03, 2026, 07:42 AM UTC Gomero Reports Q3 Loss as Net Sales Rise Gomero reported a Q3 loss, while net sales rose. M impact | EQUITY | Nov 03, 2026, 07:42 AM UTC Bayer Reports Narrower Q3 Loss and Improves Full-Year Outlook Bayer reported a third-quarter net loss attributable to stockholders of 672 million euros, versus 963 million euros a year earlier. Loss per share was 0.69 euros, compared with 0.9 M impact | EQUITY | Nov 03, 2026, 07:42 AM UTC